Skip to content

Danaher Corp DHR Stock Analysis

  • NYSE
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$230.25 up $3.91, 1.73% at close Nov 6

Last close · Previous close $226.34

Market cap
$161.86BAt the Nov 6 close
P/E ratio
37.68On last 12 months’ EPS
Diluted EPS
$6.11Last 12 months
Dividend yield
0.66%Last 12 months

Price chart

$230.25up $3.91, 1.73%Fri, Nov 6 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$226.34Nov 5
  • Volume4.06MNov 6 session
  • Avg. volume4.38MLast 21 sessions
  • 52-week range: $160.93 to $242.80; now $230.25
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Past performance, measured to the Nov 6 close. Total return includes reinvested dividends. Compared with the S&P 500, using SPY.

Return type

DHR beat the S&P 500 in 2 of 7 periods.

DHR total returns compared with the S&P 500
PeriodDHR and S&P 500vs S&P 500
Short term
1M
DHR: up 6.8%
S&P 500: down 5.6%
DHR beat the S&P 500 by 12.4 percentage points
3M
DHR: up 15.3%
S&P 500: down 4.1%
DHR beat the S&P 500 by 19.4 percentage points
YTD
DHR: up 1.2%
S&P 500: up 8.7%
DHR trailed the S&P 500 by 7.5 percentage points
1Y
DHR: up 10.1%
S&P 500: up 10.9%
DHR trailed the S&P 500 by 0.8 percentage points
Long term
3Y
DHR: up 19.9%
S&P 500: up 75.0%
+6.2% vs +20.5% a year
DHR trailed the S&P 500 by 55.1 percentage points
5Y
DHR: down 8.5%
S&P 500: up 67.8%
−1.8% vs +10.9% a year
DHR trailed the S&P 500 by 76.3 percentage points
10Y
DHR: up 256.5%
S&P 500: up 313.1%
+13.6% vs +15.2% a year
DHR trailed the S&P 500 by 56.6 percentage points

$10,000 invested in DHR 10 years ago (Nov 4, 2016) would be worth about $35,649 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.

All-time high

$332.43

Closing high on . Now 30.7% below that record.

Split-adjusted daily closes since Nov 5, 1987.

Stock splits

4

Latest: 2-for-1 on . One share bought before the first split is 16 shares today.

All 4 splits
  • 2-for-1
  • 2-for-1
  • 2-for-1
  • 2-for-1

Valuation

The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 25, 2026). Tap a metric to see how it’s calculated.

Price-to-earnings (P/E)

37.7×The Nov 6 close ÷ diluted EPS over the last 12 months ($6.11)

The range covers daily P/E ratios from Oct 28, 2021 to Nov 6, 2026, each based on the previous 12 months of earnings.

DHR trades at 37.7× its earnings over the last 12 months, above its 5-year median of 36.3×. In plain terms, buyers are paying about $38 for each $1 of profit from the past year. How to read P/E

Other valuation measures

  • 6.3×Last 12 months’ revenue
  • 3.0×Book value as of Sep 25, 2026
  • 23.3×Last 12 months’ EBITDA
  • 1.45Last 12 months’ EPS growth
  • 3.55%Last 12 months’ free cash flow
  • $182.66BAt the Nov 6 close

Build your own DHR DCF in Excel. Value Danaher with your own growth and margin assumptions.Browse DCF models Free DCF calculator

Financials

Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 25, 2026. “Last 12 months” means the four quarters from Sep 27, 2025 to Sep 25, 2026, and balance-sheet figures are as of Sep 25, 2026.

Chart periods

Revenue and net income

Last 12 months, with the change from the 12 months before

Revenue
$25.61Bup 5.5%
Net income
$4.33Bup 23.6%
Diluted EPS
$6.11up 26.0%
Last 8 fiscal quarters
Data table
DHR quarterly results
PeriodRevenueNet incomeDiluted EPS
Q4 FY24 (Dec 31, 2024)$6.54B$1.09B$1.49
Q1 FY25 (Mar 28, 2025)$5.74B$954.00M$1.32
Q2 FY25 (Jun 27, 2025)$5.94B$555.00M$0.77
Q3 FY25 (Sep 26, 2025)$6.05B$908.00M$1.27
Q4 FY25 (Dec 31, 2025)$6.84B$1.20B$1.68
Q1 FY26 (Mar 27, 2026)$5.95B$1.03B$1.45
Q2 FY26 (Jun 26, 2026)$6.27B$870.00M$1.23
Q3 FY26 (Sep 25, 2026)$6.55B$1.24B$1.75

Margins

  • Gross 58.6%
  • Operating 20.4%
  • Net 16.9%

The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you

Cash flow

  • $5.75BLast 12 months
  • Operating cash flow$6.86BLast 12 months
  • Capital spending$1.11BLast 12 months
  • 22.5%Last 12 months

Shareholder returns

  • $814.00MLast 12 months
  • Dividends paid$1.02BLast 12 months
  • Total returned$1.83BLast 12 months
    32% of free cash flow

Balance sheet

  • $5.68BAs of Sep 25, 2026
  • Total debt$26.48BAs of Sep 25, 2026
  • Net debt$20.80BAs of Sep 25, 2026
  • 1.63As of Sep 25, 2026
  • 0.49As of Sep 25, 2026

Financial strength

  • 7 of 9Last 12 months
    vs the 12 before
  • 8.2%Last 12 months
  • 4.9%Last 12 months

Dividends

Cash dividends per share by ex-dividend year, adjusted for splits.

Dividends per share

By ex-dividend date, split-adjusted
Data table
DHR dividends per share by year
YearPer share
2016$25.34
2017$0.56
2018$0.64
2019$0.68
2020$0.72
2021$0.84
2022$1.00
2023$29.24
2024$1.08
2025$1.28
2026 (to date)$1.20

Dividend details

  • $1.52Per share, last 12 months
  • 0.66%; 5-yr low 0.19%, 5-yr high 15.80%Last 12 months
  • $0.40Ex-dividend
  • FrequencyQuarterly4 payments in the last 12 months
  • up 12.2% a yearFull years 2020–2025
  • 8 yearsThrough 2025
  • 24.9%Last 12 months

About Danaher Corp

Danaher is a leading global life sciences, diagnostics and biotechnology innovator committed to advancing the power of science and technology to improve human health. Through a connected ecosystem of industry-leading businesses, the Company works closely with customers to solve many of their most complex scientific challenges by accelerating discovery, development and the delivery of life-changing therapies. Powered by the Danaher Business System and 60,000 associates worldwide, the Company strives for continuous improvement, operational excellence and Innovation at the Speed of Life. Explore more at www.danaher.com.

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
District Of Columbia, USA
Exchange
NYSE
Asset type
Common stock
Price history since

DHR news

DHR stock FAQ

What is DHR stock’s price today?

Danaher (DHR) traded at $230.25 at the close on , up $3.91 (1.73%) from the previous close of $226.34. Over the past 52 weeks it has traded between $160.93 and $242.80.

If you invested $1,000 in DHR 10 years ago, how much would you have now?

With dividends reinvested, $1,000 invested in DHR on would be worth about $3,565 at the close on , a total return of +256.5%. The same $1,000 would be worth $915 if invested five years ago, $1,101 if invested one year ago, $10,409 if invested 20 years ago, and $73,675 if invested 30 years ago. Past performance doesn’t predict future returns.

What is Danaher’s market cap?

Danaher’s market capitalization is about $161.9 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $230.25 (how market cap works). Danaher reported 702.99M shares outstanding at the end of its latest quarter ().

What is DHR’s P/E ratio?

DHR trades at 37.7 times its diluted earnings over the four quarters to ($6.11 per share), at the close. Over the past five years its P/E has ranged from 23.3 to 51.6, with a median of 36.3. (How the P/E ratio works.)

How much revenue does Danaher make?

Danaher reported $25.6 billion of revenue over the four quarters to , up 5.5% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $6.6 billion, up 8.3% from a year earlier.

Is Danaher profitable?

Yes. Danaher earned $4.3 billion of net income over the four quarters to , a net margin of 16.9%, and its operating margin was 20.4% (what margins tell you).

What are DHR’s earnings per share?

DHR’s diluted earnings per share were $6.11 over the four quarters to , compared with $4.85 in the twelve months before. The latest quarter (Q3 FY26) brought $1.75 per share, against $1.27 a year earlier (how EPS works).

Does DHR pay a dividend?

Yes. Danaher pays a quarterly dividend. The most recent was $0.40 per share, with an ex-dividend date of . Over the last twelve months it paid $1.52 per share, a 0.66% yield at the close, and the full-year dividend has risen 8 years in a row (how dividend yield works).

Based on the last 12 months’ payments ($1.52 per share), and if the next 12 months match the last 12, 100 shares would receive about $152 over 12 months, and $1,000 over 12 months would take about 658 shares, roughly $151,505 at the close. Dividends can change.

What is DHR’s 52-week high and low?

Over the past 52 weeks DHR has traded as low as $160.93 and as high as $242.80. At $230.25 at the close on , it is 5.2% below that high and 43.1% above the low.

What is DHR’s all-time high?

DHR’s highest closing price was $332.43 on , adjusted for stock splits. At $230.25 at the close on , it is 30.7% below that record.

Has DHR stock ever split?

Yes, four times: 2-for-1 on ; 2-for-1 on ; 2-for-1 on ; 2-for-1 on . One share bought before the first split would be 16 shares today.

How has DHR stock performed?

Including dividends and measured to the close on , DHR has returned +1.2% so far this year and +10.1% over the past year, and −8.5% over five years (−1.8% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.

What sector and industry is Danaher in?

Danaher is in the Healthcare sector and the Diagnostics & Research industry, and is headquartered in District Of Columbia, USA.

What exchange does DHR trade on?

Danaher trades on the NYSE under the ticker symbol DHR. Its price history on this dashboard begins on .

Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

Contact Ryan

Get in touch

Contact Me

Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.